ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV, trading on Nasdaq under the ticker ARYD, filed its S-1 registration statement with the SEC on February 10, 2021, ahead of its initial public offering later that year. The vehicle is sponsored by ARYA Sciences Holdings IV LLC, an affiliate of Perceptive Advisors, a New York-based healthcare-focused investment manager, and represents the fourth iteration of the ARYA Sciences SPAC franchise. The company was formed to pursue acquisition targets in the life sciences and biotechnology sectors. For comprehensive filing history, deal status, and institutional analytics on ARYD and the broader SPAC universe, sign up for full data access at SpacDesk.